Radosević-Radojković N, Bosković D, Lazarević B, Elezović I, Tomashević R, Rolović Z
Institute of Hematology, Clinical Centre of Sebia, Belgrade.
Srp Arh Celok Lek. 1995 Mar-Apr;123(3-4):96-9.
We present a pregnant woman, with diagnosis of acute myeloblastic leukemia (AML) established in the third trimester of pregnancy. She was delivered by Caesarean section at the end of 36th gestational week, and a healthy, mature-for-date, male infant was born. Combined chemotherapy (YU-AML protocol) was administered a week after the delivery, but the patient died after 7 months, due to resistant disease. We discuss actual problems that make an approach to pregnant patient with AML specific and individual.
我们报告一例在妊娠晚期被诊断为急性髓系白血病(AML)的孕妇。她在妊娠36周结束时接受了剖宫产,产下一名健康、足月成熟的男婴。分娩一周后给予联合化疗(YU-AML方案),但患者因疾病耐药在7个月后死亡。我们讨论了使AML孕妇的治疗方法具有特殊性和个体化的实际问题。